Skip to content
10-Q

Quarterly Report

Arbutus Biopharma Corp ABUS

0001447028-25-000115

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 191.7M sh
Shares Diluted Q2 2025 · Jun 30, 2025 192.4M sh
Shares Diluted Q2 2025 · Jun 30, 2025 191.13M sh
Shares Diluted Q2 2025 · Jun 30, 2024 188.04M sh
Shares Diluted Q2 2025 · Jun 30, 2024 181.84M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $96K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$29.14M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$33.8M
Long Term Debt Q2 2025 · Jun 30, 2025 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $37.41M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $36.33M
Stockholders Equity Q2 2025 · Jun 30, 2025 $82.98M
Stockholders Equity Q2 2025 · Mar 31, 2025 $79.16M
Stockholders Equity Q2 2025 · Dec 31, 2024 $97.37M
Stockholders Equity Q2 2025 · Jun 30, 2024 $122.45M
Stockholders Equity Q2 2025 · Mar 31, 2024 $114.64M
Stockholders Equity Q2 2025 · Dec 31, 2023 $106.02M
Current Liabilities Q2 2025 · Jun 30, 2025 $5.02M
Current Liabilities Q2 2025 · Dec 31, 2024 $15.62M
Total Liabilities Q2 2025 · Jun 30, 2025 $20.29M
Total Liabilities Q2 2025 · Dec 31, 2024 $34.34M
Current Assets Q2 2025 · Jun 30, 2025 $103.12M
Current Assets Q2 2025 · Dec 31, 2024 $127.32M
Total Assets Q2 2025 · Jun 30, 2025 $103.27M
Total Assets Q2 2025 · Dec 31, 2024 $131.71M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.01
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.12
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.11
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.21
Eps Basic Q2 2025 · Jun 30, 2025 $0.01
Eps Basic Q2 2025 · Jun 30, 2025 −$0.12
Eps Basic Q2 2025 · Jun 30, 2024 −$0.11
Eps Basic Q2 2025 · Jun 30, 2024 −$0.21
Sga Expense Q2 2025 · Jun 30, 2025 $3.33M
Sga Expense Q2 2025 · Jun 30, 2025 $9.16M
Sga Expense Q2 2025 · Jun 30, 2024 $7.55M
Sga Expense Q2 2025 · Jun 30, 2024 $12.86M
Rd Expense Q2 2025 · Jun 30, 2025 $5.5M
Rd Expense Q2 2025 · Jun 30, 2025 $14.46M
Rd Expense Q2 2025 · Jun 30, 2024 $15.55M
Rd Expense Q2 2025 · Jun 30, 2024 $30.95M
Net Income Q2 2025 · Jun 30, 2025 $2.52M
Net Income Q2 2025 · Jun 30, 2025 −$22M
Net Income Q2 2025 · Mar 31, 2025 −$24.53M
Net Income Q2 2025 · Jun 30, 2024 −$19.8M
Net Income Q2 2025 · Jun 30, 2024 −$37.67M
Net Income Q2 2025 · Mar 31, 2024 −$17.88M
Operating Income Q2 2025 · Jun 30, 2025 $1.49M
Operating Income Q2 2025 · Jun 30, 2025 −$24.21M
Operating Income Q2 2025 · Jun 30, 2024 −$21.58M
Operating Income Q2 2025 · Jun 30, 2024 −$40.95M
Revenue Q2 2025 · Jun 30, 2025 $10.74M
Revenue Q2 2025 · Jun 30, 2025 $12.5M
Revenue Q2 2025 · Jun 30, 2024 $1.73M
Revenue Q2 2025 · Jun 30, 2024 $3.26M